Michael Bubser

4.9k citations

73 papers · 3.5k indexed · h-index 35

Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research 46
- Neurotransmitter Receptor Influence on Behavior 23
Endocrine and Autonomic Systems top 2%
Biological Psychiatry top 2%
Behavioral Neuroscience top 2%
Cognitive Neuroscience top 2%
- Memory and Neural Mechanisms 11
Molecular Biology
- Receptor Mechanisms and Signaling 32
- Nicotinic Acetylcholine Receptors Study 9
- Pharmacological Receptor Mechanisms and Effects 6
Neurology
- Neurological disorders and treatments 8
- Parkinson's Disease Mechanisms and Treatments 6

Co-authors: Ariel Y. Deutch Werner Schmidt Carrie K. Jones Michael Koch Nellie Byun Jim R. Fadel P. Jeffrey Conn Craig W. Lindsley
Cited by: Cellular and Molecular Neuroscience Endocrine and Autonomic Systems Biological Psychiatry
Journals: ACS Chemical Neuroscience (7 papers)Journal of Neuroscience (6 papers)European Journal of Neuroscience (5 papers)
Partner nations: United States Germany Netherlands

In The Last Decade

Michael Bubser

71 papers receiving 3.4k citations

Peers

Countries citing papers authored by Michael Bubser

Since Specialization

Citations

This map shows the geographic impact of Michael Bubser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bubser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bubser more than expected).

Fields of papers citing papers by Michael Bubser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bubser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bubser. The network helps show where Michael Bubser may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Bubser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Bubser Line = papers co-authored together Michael Bubser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer’s disease: a single ascending-dose study in healthy participants Alzheimer s Research & Therapy ·Alexander C. Conley,Alexandra P. Key,Jennifer Urbano Blackford,弘巳秋葉,Kimberly Albert,Mingxiao Zeng,Michael Bubser,Widitiaanggifa Widitiaanggifa,P. Jeffrey Conn,Craig W. Lindsley,Carrie K. Jones,Paul Newhouse	2025	0
2	Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) ACS Chemical Neuroscience ·Julie L. Engers,Delphine Pourin,Sichen Chang,Vincent B. Luscombe,Alice L. Rodriguez,Colleen M. Niswender,Hyekyung P. Cho,Michael Bubser,Ke-Chuan Wang,Carrie K. Jones,Weimin Peng,Jerri M. Rook,Thomas M. Bridges,Olivier Boutaud,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley,Kayla J. Temple	2024	1
3	The M₄ muscarinic acetylcholine receptor positive allosteric modulator VU0467154 normalizes non‐rapid eye movement sleep deficits in non‐pathologically aged mice. Alzheimer s & Dementia ·弘巳秋葉,Kate Sarkan,Keun Hwan Park,Michael Bubser,Craig W. Lindsley,Carrie K. Jones	2023	0
4	Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators Molecular Psychiatry ·Samantha E. Yohn,Daniel J. Foster,Dan P. Covey,Mark S. Moehle,leila kafshdouz,Pedro M. García-Barrantes,Hyekyung P. Cho,Michael Bubser,Anna L. Blobaum,Max E. Joffe,Joseph F. Cheer,Carrie K. Jones,Craig W. Lindsley,P. Jeffrey Conn	2018	39
5	Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M4 PAM VU0467154 Neuropharmacology ·Robert W. Gould,Michael Grannan,Gene Krane,Emin U. Ulugergerli,Michael Bubser,Thomas M. Bridges,Jürgen Wess,Michael W. Wood,Nicholas J. Brandon,Mark E. Duggan,Colleen M. Niswender,Craig W. Lindsley,P. Jeffrey Conn,Carrie K. Jones	2017	39
6	VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy Journal of Pharmacology and Experimental Therapeutics ·Hilary Highfield Nickols,Marcos Gonçalves Adriano,Karen J. Gregory,Alexandre Magdzinski,木下和也,Shaun R. Stauffer,Kyle A. Emmitte,Michael Bubser,Wenjie Peng,Michael T. Nedelcovych,Analisa D. Thompson,Xiaohua Lv,Zixiu Xiang,J. Scott Daniels,Colleen M. Niswender,Craig W. Lindsley,Carrie K. Jones,P. Jeffrey Conn	2015	28
7	Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist Neuropharmacology ·Hanna Iderberg,Siddharth Narayanan,Analisa D. Thompson,Michael Bubser,Colleen M. Niswender,Corey R. Hopkins,Craig W. Lindsley,P. Jeffrey Conn,Carrie K. Jones,M. Angela Cenci	2015	42
8	Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia Neuropsychopharmacology ·Carrie K. Jones,Nellie Byun,Michael Bubser	2011	162
9	The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease Journal of Pharmacology and Experimental Therapeutics ·Carrie K. Jones,Michael Bubser,Analisa D. Thompson,Jonathan W. Dickerson,N. Turle-Lorenzo,Marianne Amalric,Anna L. Blobaum,Thomas M. Bridges,Ryan D. Morrison,Satyawan Jadhav,Darren W. Engers,Bhui Pratyasa,Sergey V. Vlasenko,J. Scott Daniels,Craig W. Lindsley,Corey R. Hopkins,P. Jeffrey Conn,Colleen M. Niswender	2011	81
10	Novel Selective Allosteric Activator of the M₁Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats Journal of Neuroscience ·Carrie K. Jones,Ashley E. Brady,Albert A. Davis,Zixiu Xiang,Michael Bubser,Mohammed Noor Tantawy,In Gwan Kim,Thomas M. Bridges,J. Phillip Kennedy,Stefania Risso Bradley,Todd E. Peterson,M. Sib Ansari,Ronald M. Baldwin,Robert Kessler,Ariel Y. Deutch,James J. Lah,Allan I. Levey,Craig W. Lindsley,P. Jeffrey Conn	2008	203
11	The distribution and origin of the calretinin‐containing innervation of the nucleus accumbens of the rat European Journal of Neuroscience ·Michael Bubser,Jennifer L. Scruggs,Flavio de Paula,Ariel Y. Deutch	2000	23
12	Stress induces Fos expression in neurons of the thalamic paraventricular nucleus that innervate limbic forebrain sites Synapse ·Michael Bubser,Ariel Y. Deutch	1999	117
13	Disinhibition of the mediodorsal thalamus induces Fos-like immunoreactivity in both pyramidal and GABA-containing neurons in the medial prefrontal cortex of rats, but does not affect prefrontal extracellular GABA levels Synapse ·Michael Bubser,J.M. de Brabander,Wia Timmerman,Matthijs G.P. Feenstra,Hirona Touji,Ryuichi Ishikawa,J.F.M. Van Uum,Ben H.C. Westerink	1998	25
14	Modulatory role of catecholamines in the transsynaptic expression of c-fos in the rat medial prefrontal cortex induced by disinhibition of the mediodorsal thalamus: a study employing microdialysis and immunohistochemistry Brain Research ·Michael Bubser,Matthijs G.P. Feenstra,Hirona Touji,M.H.A. Botterblom,Rocío Maseda Pedrero,Chris W. Pool	1997	16
15	Behavioral and neurochemical actions of the strychnine-insensitive glycine receptor antagonist, 7-chlorokynurenate, in rats European Journal of Pharmacology ·B. D. Kretschmer,Michael Bubser,Werner Schmidt	1995	13
16	Injection of apomorphine into the medial prefrontal cortex of the rat increases haloperidol-induced catalepsy Biological Psychiatry ·Michael Bubser,Havva Daryafti	1994	14
17	Deficient Sensorimotor Gating After 6‐Hydroxydopamine Lesion of the Rat medial Prefrontal Cortex is Reversed by Haloperidol European Journal of Neuroscience ·Michael Koch,Michael Bubser	1994	113
18	6-Hydroxydopamine lesion of the rat prefrontal cortex impairs motor initiation but not motor execution Experimental Brain Research ·Wolfgang Hauber,Michael Bubser,Katharina Thanner	1994	26
19	Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats European Journal of Pharmacology ·Michael Bubser,Chou Chia-Chun,力杜,Werner Schmidt	1992	130
20	Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats Pharmacology Biochemistry and Behavior ·Werner Schmidt,Michael Bubser	1989	147

About Michael Bubser

Michael Bubser is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems, Cognitive Neuroscience, Molecular Biology and Neurology, having authored 73 papers that have together received 3.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (46 papers), Receptor Mechanisms and Signaling (32 papers), Neurotransmitter Receptor Influence on Behavior (23 papers), Memory and Neural Mechanisms (11 papers), Nicotinic Acetylcholine Receptors Study (9 papers), Neurological disorders and treatments (8 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.3k citations), Endocrine and Autonomic Systems (419 citations), Biological Psychiatry (147 citations), Behavioral Neuroscience (209 citations) and Cognitive Neuroscience (1.1k citations). Michael Bubser has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Ariel Y. Deutch, Werner Schmidt, Carrie K. Jones, Michael Koch, Nellie Byun, Jim R. Fadel, P. Jeffrey Conn, Craig W. Lindsley, Wolfgang Hauber and Jennifer L. Scruggs. Their work appears in journals such as ACS Chemical Neuroscience, Journal of Neuroscience, European Journal of Neuroscience, Neuropharmacology and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact